申请人:Wang Tao
公开号:US20120093767A1
公开(公告)日:2012-04-19
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
该披露提供了I式化合物,包括药用可接受的盐,以及使用该化合物的组合物和方法。该化合物具有对丙型肝炎病毒(HCV)的活性,并可用于治疗HCV感染者。